Tarek Waked Hammoud, MD
Surgery · Georgetown, DENPI 1699941864
Payments from drug & device makers
What this record shows
This record is dominated by education: $7,000 of the $10,502 with a category attached, or 66.7%. Intuitive Surgical accounts for 84.0% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $8,546 and has fallen 98.9% since, to $98 in 2025.
Across 48 payments — averaging $218.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- W. L. Gore & Associates, Inc.$491
- AbbVie$309
- Johnson & Johnson$182
- Medtronic$159
- Olympus America Inc.$136
- plus $403 from 5 others
What the payments were for
- Travel & lodging$1,22112%
- Food & beverage$2,28122%
- Education$7,00067%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 21 | $8,821 |
| W. L. Gore & Associates, Inc. | 7 | $491 |
| AbbVie | 3 | $309 |
| Johnson & Johnson | 6 | $182 |
| Medtronic | 2 | $159 |
| Olympus America Inc. | 3 | $136 |
| Novo Nordisk | 2 | $130 |
| Idorsia Pharmaceuticals US Inc | 1 | $125 |
| Boston Scientific | 1 | $116 |
| Endo Pharmaceuticals Inc. | 1 | $19 |
| Conmed Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$8,194
- VRAYLAR$125
- QUVIVIQ$125
- SpyScope DS$116
- GORE SYNECOR Biomaterial$116
How this compares
$10,502 in reported general payments places this provider in the 85th percentile of 89 surgery providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 75 | $1,318 |
| Enoxaparin Sodium | 14 | $1,144 |
| Ondansetron OdtOndansetron | 23 | $364 |
| Sucralfate | 11 | $271 |
| Cyanocobalamin InjectionCyanocobalamin (Vitamin B-12) | 11 | $90 |
| Oxycodone Hcl | 15 | $21 |
Paid to pharmacies, not to this prescriber.
Other surgery in Georgetown
- Christopher ManieriGeorgetown$8K
- Peter SantoroWilmington$166K
- Karen BarbosaRehoboth Beach$60K
- Lydell LettsomeDover$32K
- M Lisa AtteberyRehoboth Beach$22K
- Erik StancofskiLewes$19K
- Mark FaccioloLewes$17K
- Veronica Bustillo-ArucaNewark$15K
- Barath KrishnanDover$15K
- David CloneyMilford$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.